Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Risk factors for recurrent cardiovascular events in CKD: results from the KNOW-CKD study.

In CKD, recurrent CV risk is driven not only by traditional factors, particularly diabetes, but also by markers of vascular injury and inflammation, and strategies targeting both metabolic and inflammatory pathways may be critical to reducing recurrent CV burden.

Eunjeong Kang, Dha Woon Im, Minsang Kim et al. · 0 citations
Open access Sep 2026

Incretin-based therapies in diabetic kidney disease: toward integrated cardio-kidney-metabolic disease modification.

Mechanical insights from translational studies further suggest that GLP-1 receptor activation promotes metabolic decongestion, improves intrarenal hemodynamics, and attenuates inflammatory and fibrotic pathways, with emerging signals for cardiovascular and renal benefit.

Yaeni Kim, Eun Young Lee · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.